Dr. EDITA MIŠTINIENĖ is an international professional with over 20 years of experience in pharmaceutical industry and life sciences, on positions ranging from R&D projects manager to Chief Scientific Officer and Director at Lithuanian, Spanish, American and Israeli companies. With a group of fellow scientists, she established biotechnology company Profarma leading in creation of new generation biologic drug and new life-saving treatments. The technology is unique by its complexity and innovative approach. In 2017, it was applied to produce cosmetics, and the new Lithuanian brand Peonia appeared on the market.
Dr. Edita Mištinienė
CEO at Profarma, CSO at Boston Biopharma